Pembrolizumab near the end of life in patients with metastatic pancreatic cancer: a multi-site consecutive series to examine survival and patient treatment burden
Michael H. Storandt, Nguyen H. Tran, Nichole Martin, Aminah Jatoi
Topics & Concepts
PembrolizumabMedicinePancreatic cancerSeries (stratigraphy)OncologyCancerInternal medicineImmunotherapyPaleontologyBiologyPancreatic and Hepatic Oncology ResearchCancer Immunotherapy and BiomarkersEconomic and Financial Impacts of Cancer